Genomics Collaborative Signs Up Five Pharmas to Access Its Access | GenomeWeb

NEW YORK, Aug. 22 – Genomics Collaborative said on Wednesday that it has signed up its first five biopharmaceutical companies to access its newly launched database of DNA, sera, and tissue samples.

Pharmacia Corporation, GlaxoSmithKline, and Exelixis Corporation were three of the five companies that Genomics Collaborative said in a statement were new clients. A company spokesman would not disclose the names of the two remaining firms, but confirmed that they are based in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.